Tambocor is the brand name for flecainide [1]. Flecainide is a medication used to treat certain types of heart rhythm disorders [2].
What is Flecainide used for?
Flecainide is prescribed to prevent and treat paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation in patients without structural heart disease [3]. It is also used to suppress chronic, incapacitating, drug-resistant ventricular arrhythmias [3].
How does Flecainide work?
Flecainide is a Class Ic antiarrhythmic agent. It works by blocking fast sodium channels in the heart muscle, which slows the electrical conduction and helps to stabilize the heart rhythm [4].
What is the difference between Flecainide and Tambocor?
Tambocor is the brand name under which the generic drug flecainide is marketed [1]. Therefore, they are the same medication.
When does the patent for Flecainide expire?
Information regarding specific patent expiry dates for flecainide is not readily available. However, the original patents for flecainide have long since expired, allowing for the availability of generic versions [5]. DrugPatentWatch.com tracks patent information for pharmaceuticals [6].
Are there alternatives to Flecainide?
Other medications used to treat heart rhythm disorders include amiodarone, sotalol, and propafenone, among others [7]. The choice of treatment depends on the specific condition, patient factors, and potential side effects [3][7].